Natural pet treat brand Dogsee Chew has raised $8 million in its Series B round led by Ektha.com, with participation from promoters, Shivanssh Holdings, and Poddar Family Office.
With this latest funding, the company has secured a total of $22 million in investments to date. Previously, in January 2022, Dogsee Chew raised $6.7 million in its Series A round, led by Mankind Pharma alongside existing investor Sixth Sense Ventures.
The newly acquired capital will be directed toward scaling up manufacturing capabilities. This includes expanding existing factories and constructing a new production facility. Additionally, the company aims to bolster its Amazon Global Selling strategy, fostering international market growth, with a significant focus on expanding into the United States and Canada in 2025.
Founded in 2015 by husband-wife duo Bhupendra Khanal and Sneh Sharma, Dogsee Chew has built a presence in more than 30 countries. The startup specializes in 100 percent vegetarian, all-natural, human-grade, and protein-rich dog treats.
“With the premiumization of the pet food category on the rise, the demand for our human-grade chews is exploding. This investment ensures we are well-prepared to meet this demand by scaling production and expanding our presence globally. To make our products more accessible, we also plan to open distribution hubs in key international markets, allowing our retail partners to seamlessly access Dogsee Chews with shorter lead times,” said Bhupendra Khanal.
As the pet food industry continues to shift toward high-quality, natural offerings, Dogsee Chew is well-positioned to capitalize on this trend and strengthen its global footprint.
